GlobalData provides unique and market-leading data and insights into the metabolic disorder market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Diabetic Foot Infection (DFI) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021" provides an overview of Diabetic Foot Infection (DFI) Clinical trials scenario. This report provides top...

Hyperinsulinemia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Hyperinsulinemia - Global Clinical Trials Review, H2, 2021" provides an overview of Hyperinsulinemia Clinical trials scenario. This report provides top line data relating to the clinical...

Hyperglycemia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Hyperglycemia - Global Clinical Trials Review, H2, 2021" provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical...

Hypoglycemia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Hypoglycemia - Global Clinical Trials Review, H2, 2021" provides an overview of Hypoglycemia Clinical trials scenario. This report provides top line data relating to the clinical...

Diabetic Foot Ulcers – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Diabetic Foot Ulcers" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic...

Hypoglycemia Drug Market Size, Share & Trends Analysis and Forecast 2021-2030

  • $10,995
  • November 2021
Hypoglycemia, or low blood sugar, is primarily observed in diabetic patients who are receiving insulin therapy. In other instances, such as life-threatening illness conditions, end-stage liver disease, sepsis, malnourishment, or...

Hypoglycemia – Epidemiology Forecast to 2030

  • $3,995
  • November 2021
Hypoglycemia is a condition in which a person’s glucose, or blood sugar, level is lower than normal. It most often, although not exclusively, occurs in patients with drug-treated type 1...

Homozygous Familial Hypercholesterolemia (HoFH) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Homozygous Familial Hypercholesterolemia (HoFH) - Global Clinical Trials Review, H2, 2021" provides an overview of Homozygous Familial Hypercholesterolemia (HoFH) Clinical trials scenario. This report provides top...

Heterozygous Familial Hypercholesterolemia (heFH) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • August 2021
GlobalData's clinical trial report, “Heterozygous familial hypercholesterolemia (heFH) - Global Clinical Trials Review, H2, 2021" provides an overview of Heterozygous familial hypercholesterolemia (heFH) Clinical trials scenario. This report provides top...

Diabetic Foot Ulcers – Global Clinical Trials Review, H1, 2021

  • $2,500
  • June 2021
GlobalData's clinical trial report, “Diabetic Foot Ulcers - Global Clinical Trials Review, H1, 2021" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data...